Ticker: CO, Company: China Cord Blood Corp, Type: 6-K, Date: 2018-01-31
Original SEC Filing: Click here

---

Webplus: CO/20180131/6-K/2_EX-99.1/000.htm SEC Original: a18-3859_1ex99d1.htm
Nanjing Ying Peng Becomes Major Shareholder of China Cord Blood Corporation HONG KONG, China, January 31, 2018 — China Cord Blood Corporation (NYSE: CO) (“CCBC” or the “Company”), a leading cord blood bank operator in China, today announced that Nanjing Ying Peng Hui Kang Medical Industry Investment Partnership (limited partnership) (“Nanjing Ying Peng”), via its subsidiary, has become a major

---

---

Webplus: CO/20180131/6-K/1/000.htm SEC Original: a18-3859_16k.htm
FORM 6-K 8 CHINA CORD BLOOD CORPORATION 48 th Floor, Bank of China Tower 1 Garden Road Central Hong Kong S.A.R. Form 20-F x Form 40-F o o o Yes o No x Other Events On January 31, 2017, the Company issued a press release announcing the consummation of a previously disclosed conditional sale agreement entered into on December 30,

---

Company Info:

Ticker: CO, Company: China Cord Blood Corp, Type: 6-K, Date: 2018-01-31CIK: 0001467808, Location: K3, SIC: 6770, SIC Desc: BLANK CHECKS
Business Phone & Address:
48 FL., BANK OF CHINA TOWER, 1 GARDEN ROAD
CENTRAL HONG KONG, K3 000000